{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 AST-GN Gentamicin"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K163563",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121546"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LTW",
        "LTT"
    ],
    "Summary Letter Date": "March 13, 2017",
    "Summary Letter Received Date": "December 19, 2016",
    "Submission Date": "December 16, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Gentamicin"
    ],
    "Specimen Type(s)": [
        "Isolated colonies of Gram negative bacilli",
        "Staphylococcus spp.",
        "Enterococcus spp.",
        "Streptococcus spp.",
        "Clinically significant yeast"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2",
        "VITEK\u00ae 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Minimum inhibitory concentration (MIC) microdilution",
        "Automated susceptibility testing"
    ],
    "Methodologies": [
        "Microdilution",
        "Automated antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Card"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST-GN Gentamicin antimicrobial susceptibility testing for Gram negative bacilli using VITEK 2 platforms.",
    "Indications for Use Summary": "Antimicrobial susceptibility test for Gram negative bacilli using VITEK 2 and VITEK 2 Compact systems to aid in determining in vitro susceptibility to Gentamicin.",
    "fda_folder": "Microbiology"
}